Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil

Novaes, Hillegonda Maria Dutilh; Itria, Alexander; Silva, Gulnar Azevedo e; Sartori, Ana Marli Christovam; Rama, Cristina Helena; Soárez, Patrícia Coelho de

doi:10.6061/clinics/2015(04)12

Cited by 22 publications

(28 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In 2012, cervical cancer was the fourth most common type of cancer among women worldwide with an estimated 528,000 new cases and 266,000 deaths; 87% of deaths occurred in low and middle-income countries [ 3 ]. Treatment costs for cervical cancer remain high with low survival probabilities due to late diagnosis in many countries [ 4 , 5 ]. HPV vaccines offer an approach for primary prevention of HPV infection that can eventually reduce the health and economic burden of cervical cancer.…”

Section: Introductionmentioning

confidence: 99%

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study

Minh

Jit

2017

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundCervical cancer is currently the leading cause of cancer mortality among women in South Vietnam and the second leading cause of cancer mortality in North Vietnam. Human papillomavirus (HPV) vaccination has the potential to substantially decrease this burden. The World Health Organization (WHO) recommends that a cost-effectiveness analysis of HPV vaccination is conducted before nationwide introduction.MethodsThe Papillomavirus Rapid Interface for Modeling and Economics (PRIME) model was used to evaluate the cost-effectiveness of HPV vaccine introduction. A costing study based on expert panel discussions, interviews and hospital case note reviews was conducted to explore the cost of cervical cancer care.ResultsThe cost of cervical cancer treatment ranged from US$368 – 11400 depending on the type of hospital and treatment involved. Under Gavi-negotiated prices of US$4.55, HPV vaccination is likely to be very cost-effective with an incremental cost per disability-adjusted life year (DALY) averted in the range US$780 - 1120. However, under list prices for Cervarix and Gardasil in Vietnam, the incremental cost per DALY averted for HPV vaccination can exceed US$8000.ConclusionHPV vaccine introduction appears to be economically attractive only if Vietnam is able to procure the vaccine at Gavi prices. This highlights the importance of initiating a nationwide vaccination programme while such prices are still available.

show abstract

Section: Introductionmentioning

confidence: 99%

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study

Minh

Jit

2017

BMC Health Serv Res

View full text Add to dashboard Cite

show abstract

“…Some of these studies found large discrepancies between RHIS data and an estimated disease burden in populations or highlighted the lack of service provision. A few studies also used RHIS data to describe specific programs [ 60 – 64 ], conduct impact evaluations (non-programmatic) [ 65 – 68 ], and estimate costs [ 69 , 70 ]. Most of the studies investigated a communicable disease (95%), of which malaria was most studied health condition (24%).…”

Section: Resultsmentioning

confidence: 99%

Using routine health information data for research in low- and middle-income countries: a systematic review

Hung

Hoxha

Irwin

et al. 2020

BMC Health Serv Res

View full text Add to dashboard Cite

Background: Routine health information systems (RHISs) support resource allocation and management decisions at all levels of the health system, as well as strategy development and policy-making in many low-and middleincome countries (LMICs). Although RHIS data represent a rich source of information, such data are currently underused for research purposes, largely due to concerns over data quality. Given that substantial investments have been made in strengthening RHISs in LMICs in recent years, and that there is a growing demand for more real-time data from researchers, this systematic review builds upon the existing literature to summarize the extent to which RHIS data have been used in peer-reviewed research publications. Methods: Using terms 'routine health information system', 'health information system', or 'health management information system' and a list of LMICs, four electronic peer-review literature databases were searched from inception to February 202,019: PubMed, Scopus, EMBASE, and EconLit. Articles were assessed for inclusion based on predetermined eligibility criteria and study characteristics were extracted from included articles using a piloted data extraction form. Results: We identified 132 studies that met our inclusion criteria, originating in 37 different countries. Overall, the majority of the studies identified were from Sub-Saharan Africa and were published within the last 5 years. Malaria and maternal health were the most commonly studied health conditions, although a number of other health conditions and health services were also explored. Conclusions: Our study identified an increasing use of RHIS data for research purposes, with many studies applying rigorous study designs and analytic methods to advance program evaluation, monitoring and assessing services, and epidemiological studies in LMICs. RHIS data represent an underused source of data and should be made more available and further embraced by the research community in LMIC health systems.

show abstract

“…Some of these studies found large discrepancies between RHIS data and an estimated disease burden in populations or highlighted the lack of service provision. A few studies also used RHIS data to describe speci c programs [60][61][62][63][64] , conduct impact evaluations (non-programmatic) [65][66][67][68] , and estimate costs 69,70 .…”

Section: Resultsmentioning

confidence: 99%

Using Routine Health Information Data for Research in Low- and Middle-Income Countries: A Systematic Review

Hung

Hoxha

Irwin

et al. 2020

Preprint

View full text Add to dashboard Cite

Background : Routine health information systems (RHISs) support resource allocation and management decisions at all levels of the health system, as well as strategy development and policy-making in many low- and middle-income countries (LMICs). Although RHIS data represent a rich source of information, such data are currently underused for research purposes, largely due to concerns over data quality. Given that substantial investments have been made in strengthening RHISs in LMICs in recent years and that there is a growing demand for more real-time data from researchers, this systematic review builds upon the existing literature to summarize the extent to which RHIS data have been used in peer-reviewed research publications. Methods : Using terms ‘routine health information system’, ‘health information system’, or ‘health management information system’ and a list of LMICs, four electronic peer-review literature databases were searched from inception to February 20 2019: PubMed, Scopus, EMBASE, and EconLit. Articles were assessed for inclusion based on pre-determined eligibility criteria and study characteristics were extracted from included articles using a piloted data extraction form. Results : We identified 132 studies that met our inclusion criteria, originating in 37 different countries. Overall, the majority of the studies identified were from Sub-Saharan Africa and were published within the last five years. Malaria and maternal health were the most commonly studied health conditions, although a number of other health conditions and health services were also explored. Conclusions : Our study identified an increasing use of RHIS data for research purposes, with many studies applying rigorous study designs and analytic methods to advance program evaluation, monitoring and assessing services, and epidemiological studies in LMICs. RHIS data represent an underused source of data and should be made more available and further embraced by the research community in LMIC health systems.

show abstract

Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil

Cited by 22 publications

References 17 publications

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study

Using routine health information data for research in low- and middle-income countries: a systematic review

Using Routine Health Information Data for Research in Low- and Middle-Income Countries: A Systematic Review

Contact Info

Product

Resources

About